Anna P. Malykhina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna P. Malykhina has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Balachandar Nedumaran
Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, USA
4 shared publications- Joseph Hypolite
Aurora, CO
4 shared publications Randall B. Meacham
Division of Urology, Department of Surgery, School of Medicine, University of Colorado Denver, Aurora, CO, United States
4 shared publicationsSanghee Lee
Department of Urology, University of California San Diego, La Jolla, USA
4 shared publications- Alison Xiaoqiao Xie
Division of Urology, Department of Surgery, School of Medicine
3 shared publications Nao Iguchi
Affiliation Division of Urology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America
3 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1738762
Shaping the future of abdominal and pelvic pain research with novel scientific and technological advances
Abdominal and pelvic pain often originates from one or more visceral organs of the gastrointestinal, musculoskeletal (pelvic floor), urinary, or reproductive systems. Over the past decade, research efforts on abdominal and pelvic pain have advanced considerably, driven by the discovery of new molecular targets, signaling pathways, targeted genetic editing, the use of human tissues, and comprehensive multiomic analyses. Increasingly, the field prioritizes combinatorial and integrative studies that bridge human clinical research with relevant animal models to accelerate the development of novel therapies for affected patients. In addition to established areas of pain research—such as the modulatory role of the central nervous system in chronic pelvic pain (CPP), stress-induced visceral hypersensitivity, sex differences, brain-gut interactions, microbiome influences, comorbidities, and neuromodulation—new research directions continue to emerge. These include exploring the effects of inflammaging and immune regulation in transition from acute to CPP, applying microphysiological systems (MPS) in pain research studies, integrating multiomics analyses, and employing combined artificial intelligence (AI) approaches. This article presents current perspectives on cutting-edge scientific trends and technological innovations shaping the field of abdominal and pelvic pain research.
- 26 February 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1738762
Open AccessShaping the future of abdominal and pelvic pain research with novel scientific and technological advances
Abdominal and pelvic pain often originates from one or more visceral organs of the gastrointestinal, musculoskeletal (pelvic floor), urinary, or reproductive systems. Over the past decade, research efforts on abdominal and pelvic pain have advanced considerably, driven by the discovery of new molecular targets, signaling pathways, targeted genetic editing, the use of human tissues, and comprehensive multiomic analyses. Increasingly, the field prioritizes combinatorial and integrative studies that bridge human clinical research with relevant animal models to accelerate the development of novel therapies for affected patients. In addition to established areas of pain research—such as the modulatory role of the central nervous system in chronic pelvic pain (CPP), stress-induced visceral hypersensitivity, sex differences, brain-gut interactions, microbiome influences, comorbidities, and neuromodulation—new research directions continue to emerge. These include exploring the effects of inflammaging and immune regulation in transition from acute to CPP, applying microphysiological systems (MPS) in pain research studies, integrating multiomics analyses, and employing combined artificial intelligence (AI) approaches. This article presents current perspectives on cutting-edge scientific trends and technological innovations shaping the field of abdominal and pelvic pain research.
- 24 November 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105675
Structural and functional bladder changes associated with disrupted voiding cycle in a murine model of cutaneous vesicostomy
- 24 November 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105675
Structural and functional bladder changes associated with disrupted voiding cycle in a murine model of cutaneous vesicostomy
- 1 January 2025
- Published by e-Century Publishing Corporation in American Journal of Clinical and Experimental Urology
- Vol. 13 (3) , 194-214
Comparative transcriptome profiling of the lumbosacral dorsal root ganglia reveals sexually dimorphic gene expression in a murine model of coronavirus-induced neurodegeneration
Neuroinflammation of the central nervous system (CNS) triggers long-lasting neurodegenerative changes associated with the development of neurogenic dysfunction in the pelvic organs. We previously described the symptoms of voiding dysfunction in a mouse model of multiple sclerosis (MS) induced by a coronaviral infection with mouse hepatitis virus (MHV). The aim of the current study was to identify immune, inflammatory and neuronal changes in the lumbosacral (L6-S2) dorsal root ganglia (DRG) innervating the lower urinary tract (LUT) after severe neurodegeneration in the CNS. Adult C57BL/6 male (N=18) and female (N=18) mice received either an intracranial injection of MHV (coronavirus-induced encephalomyelitis, CIE group), or sterile saline (control group). Dorsal root ganglia were collected from mice of both sexes at 1 and 4 weeks, followed by isolation of total RNA and bulk RNA sequencing. Transcriptome analysis of LS DRG identified a sex dependent expression of the genes at baseline with females having an increased expression of the immune system and extracellular matrix (ECM) related differentially expressed genes (DEGs) whereas males showed an upregulation of the genes belonging to protein synthesis, folding, and post-translational phosphorylation. Acute neuroinflammation (1 wk post-infection) triggered extensive immune responses involving the families of interferons (Ifna2, Ifng, Ifnl1), interleukins (Il1a, Il1b, Il6), toll-like receptors (Tlr9, Tlr7), and guanylate-binding proteins (GTPases, Gbp) in both, CIE males and females. However, at a later stage of neurodegeneration (4 wks post-infection), the number of upregulated DEGs was down 6-fold in CIE males, whereas in CIE females the downregulated pathways were predominant, and mostly included genes encoding motor proteins (Myh7, Myl2, Myl3, Tnnt1, TnnI1, Dnah5). Among the pathways upregulated in males but downregulated in females at both time points were phagosome formation pathway, neutrophil extracellular trap signaling, and hepatic fibrosis pathway. This study confirmed a differential expression of immune, inflammatory, and neural DEGs in sensory ganglia of male and female mice undergoing CNS neurodegeneration and neuroinflammation. The obtained results suggest a functional role of sex-dependent sensory interoception in the development of neurogenic LUTS in a coronavirus-induced murine model of MS.
- 1 January 2025
- Published by e-Century Publishing Corporation in American Journal of Clinical and Experimental Urology
- Vol. 13 (3) , 194-214
Comparative transcriptome profiling of the lumbosacral dorsal root ganglia reveals sexually dimorphic gene expression in a murine model of coronavirus-induced neurodegeneration
Neuroinflammation of the central nervous system (CNS) triggers long-lasting neurodegenerative changes associated with the development of neurogenic dysfunction in the pelvic organs. We previously described the symptoms of voiding dysfunction in a mouse model of multiple sclerosis (MS) induced by a coronaviral infection with mouse hepatitis virus (MHV). The aim of the current study was to identify immune, inflammatory and neuronal changes in the lumbosacral (L6-S2) dorsal root ganglia (DRG) innervating the lower urinary tract (LUT) after severe neurodegeneration in the CNS. Adult C57BL/6 male (N=18) and female (N=18) mice received either an intracranial injection of MHV (coronavirus-induced encephalomyelitis, CIE group), or sterile saline (control group). Dorsal root ganglia were collected from mice of both sexes at 1 and 4 weeks, followed by isolation of total RNA and bulk RNA sequencing. Transcriptome analysis of LS DRG identified a sex dependent expression of the genes at baseline with females having an increased expression of the immune system and extracellular matrix (ECM) related differentially expressed genes (DEGs) whereas males showed an upregulation of the genes belonging to protein synthesis, folding, and post-translational phosphorylation. Acute neuroinflammation (1 wk post-infection) triggered extensive immune responses involving the families of interferons (Ifna2, Ifng, Ifnl1), interleukins (Il1a, Il1b, Il6), toll-like receptors (Tlr9, Tlr7), and guanylate-binding proteins (GTPases, Gbp) in both, CIE males and females. However, at a later stage of neurodegeneration (4 wks post-infection), the number of upregulated DEGs was down 6-fold in CIE males, whereas in CIE females the downregulated pathways were predominant, and mostly included genes encoding motor proteins (Myh7, Myl2, Myl3, Tnnt1, TnnI1, Dnah5). Among the pathways upregulated in males but downregulated in females at both time points were phagosome formation pathway, neutrophil extracellular trap signaling, and hepatic fibrosis pathway. This study confirmed a differential expression of immune, inflammatory, and neural DEGs in sensory ganglia of male and female mice undergoing CNS neurodegeneration and neuroinflammation. The obtained results suggest a functional role of sex-dependent sensory interoception in the development of neurogenic LUTS in a coronavirus-induced murine model of MS.
- 18 July 2024
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 390 (2) , 186-187
Special Section on Therapeutic Approaches to Treat Disorders of the Urinary and Gastrointestinal Tracts—Editorial
- 18 July 2024
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 390 (2) , 186-187
Special Section on Therapeutic Approaches to Treat Disorders of the Urinary and Gastrointestinal Tracts—Editorial
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 326 (6) , F957-F970
Long-term follow-up of TREK-1 KO mice reveals the development of bladder hypertrophy and impaired bladder smooth muscle contractility with age
This study compared voiding function and bladder phenotypes in global and smooth muscle-specific TREK-1 KO mice. We found significant age-related changes in bladder contractility, suggesting that the lack of TREK-1 channel activity might contribute to age-related changes in bladder smooth muscle physiology.
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 326 (6) , F957-F970
Long-term follow-up of TREK-1 KO mice reveals the development of bladder hypertrophy and impaired bladder smooth muscle contractility with age
This study compared voiding function and bladder phenotypes in global and smooth muscle-specific TREK-1 KO mice. We found significant age-related changes in bladder contractility, suggesting that the lack of TREK-1 channel activity might contribute to age-related changes in bladder smooth muscle physiology.
- 2 April 2024
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 390 (2) , 222-232
Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome Management: Research Advances, Experimental Targets, and Future Directions
- 2 April 2024
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 390 (2) , 222-232
Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome Management: Research Advances, Experimental Targets, and Future Directions
- Open Access
- 30 August 2023
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 4, 1254682
Editorial: Emerging trends in abdominal and pelvic pain
Editorial: Emerging trends in abdominal and pelvic pain
- 30 August 2023
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 4, 1254682
Open AccessEditorial: Emerging trends in abdominal and pelvic pain
Editorial: Emerging trends in abdominal and pelvic pain
- Open Access
- 1 January 2023
- Published by XMLink in Investigative and Clinical Urology
- Vol. 64 (2) , 189-196
Anti-fibrotic effect of tocotrienols for bladder dysfunction due to partial bladder outlet obstruction
Iguchi N, et al. Investig Clin Urol. 2023 Feb;64:e17. https://doi.org/10.4111/icu.20220328
- 1 January 2023
- Published by XMLink in Investigative and Clinical Urology
- Vol. 64 (2) , 189-196
Open AccessAnti-fibrotic effect of tocotrienols for bladder dysfunction due to partial bladder outlet obstruction
Iguchi N, et al. Investig Clin Urol. 2023 Feb;64:e17. https://doi.org/10.4111/icu.20220328
- Open Access
- 9 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0278918
Differential transcriptomic changes in the central nervous system and urinary bladders of mice infected with a coronavirus
Multiple sclerosis (MS) often leads to the development of neurogenic lower urinary tract symptoms (LUTS). We previously characterized neurogenic bladder dysfunction in a mouse model of MS induced by a coronavirus, mouse hepatitis virus (MHV). The aim of the study was to identify genes and pathways linking neuroinflammation in the central nervous system with urinary bladder (UB) dysfunction to enhance our understanding of the mechanisms underlying LUTS in demyelinating diseases. Adult C57BL/6 male mice (N = 12) received either an intracranial injection of MHV (coronavirus-induced encephalomyelitis, CIE group), or sterile saline (control group). Spinal cord (SC) and urinary bladders (UB) were collected from CIE mice at 1 wk and 4 wks, followed by RNA isolation and NanoString nCounter Neuroinflammation assay. Transcriptome analysis of SC identified a significantly changed expression of >150 genes in CIE mice known to regulate astrocyte, microglia and oligodendrocyte functions, neuroinflammation and immune responses. Two genes were significantly upregulated (Ttr and Ms4a4a), and two were downregulated (Asb2 and Myct1) only in the UB of CIE mice. Siglec1 and Zbp1 were the only genes significantly upregulated in both tissues, suggesting a common transcriptomic link between neuroinflammation in the CNS and neurogenic changes in the UB of CIE mice.
- 9 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0278918
Open AccessDifferential transcriptomic changes in the central nervous system and urinary bladders of mice infected with a coronavirus
Multiple sclerosis (MS) often leads to the development of neurogenic lower urinary tract symptoms (LUTS). We previously characterized neurogenic bladder dysfunction in a mouse model of MS induced by a coronavirus, mouse hepatitis virus (MHV). The aim of the study was to identify genes and pathways linking neuroinflammation in the central nervous system with urinary bladder (UB) dysfunction to enhance our understanding of the mechanisms underlying LUTS in demyelinating diseases. Adult C57BL/6 male mice (N = 12) received either an intracranial injection of MHV (coronavirus-induced encephalomyelitis, CIE group), or sterile saline (control group). Spinal cord (SC) and urinary bladders (UB) were collected from CIE mice at 1 wk and 4 wks, followed by RNA isolation and NanoString nCounter Neuroinflammation assay. Transcriptome analysis of SC identified a significantly changed expression of >150 genes in CIE mice known to regulate astrocyte, microglia and oligodendrocyte functions, neuroinflammation and immune responses. Two genes were significantly upregulated (Ttr and Ms4a4a), and two were downregulated (Asb2 and Myct1) only in the UB of CIE mice. Siglec1 and Zbp1 were the only genes significantly upregulated in both tissues, suggesting a common transcriptomic link between neuroinflammation in the CNS and neurogenic changes in the UB of CIE mice.
- Open Access
- 25 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0262769
Pharmacogenetic inhibition of lumbosacral sensory neurons alleviates visceral hypersensitivity in a mouse model of chronic pelvic pain
The study investigated the cellular and molecular mechanisms in the peripheral nervous system (PNS) underlying the symptoms of urologic chronic pelvic pain syndrome (UCPPS) in mice. This work also aimed to test the feasibility of reversing peripheral sensitization in vivo in alleviating UCPPS symptoms. Intravesical instillation of vascular endothelial growth factor A (VEGFA) was used to induce UCPPS-like symptoms in mice. Spontaneous voiding spot assays and manual Von Frey tests were used to evaluate the severity of lower urinary tract symptoms (LUTS) and visceral hypersensitivity in VEGFA-instilled mice. Bladder smooth muscle strip contractility recordings (BSMSC) were used to identify the potential changes in myogenic and neurogenic detrusor muscle contractility at the tissue-level. Quantitative real-time PCR (qPCR) and fluorescent immunohistochemistry were performed to compare the expression levels of VEGF receptors and nociceptors in lumbosacral dorsal root ganglia (DRG) between VEGFA-instilled mice and saline-instilled controls. To manipulate primary afferent activity, Gi-coupled Designer Receptors Exclusively Activated by Designer Drugs (Gi-DREADD) were expressed in lumbosacral DRG neurons of TRPV1-Cre-ZGreen mice via targeted adeno-associated viral vector (AAVs) injections. A small molecule agonist of Gi-DREADD, clozapine-N-oxide (CNO), was injected into the peritoneum (i. p.) in awake animals to silence TRPV1 expressing sensory neurons in vivo during physiological and behavioral recordings of bladder function. Intravesical instillation of VEGFA in the urinary bladders increased visceral mechanical sensitivity and enhanced RTX-sensitive detrusor contractility. Sex differences were identified in the baseline detrusor contractility responses and VEGF-induced visceral hypersensitivity. VEGFA instillations in the urinary bladder led to significant increases in the mRNA and protein expression of transient receptor potential cation channel subfamily A member 1 (TRPA1) in lumbosacral DRG, whereas the expression levels of transient receptor potential cation channel subfamily V member 1 (TRPV1) and VEGF receptors (VEGFR1 and VEGFR2) remained unchanged when compared to saline-instilled animals. Importantly, the VEGFA-induced visceral hypersensitivity was reversed by Gi-DREADD-mediated neuronal silencing in lumbosacral sensory neurons. Activation of bladder VEGF signaling causes sensory neural plasticity and visceral hypersensitivity in mice, confirming its role of an UCPPS biomarker as identified by the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) research studies. Pharmacogenetic inhibition of lumbosacral sensory neurons in vivo completely reversed VEGFA-induced pelvic hypersensitivity in mice, suggesting the strong therapeutic potential for decreasing primary afferent activity in the treatment of pain severity in UCPPS patients.
- 25 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0262769
Open AccessPharmacogenetic inhibition of lumbosacral sensory neurons alleviates visceral hypersensitivity in a mouse model of chronic pelvic pain
The study investigated the cellular and molecular mechanisms in the peripheral nervous system (PNS) underlying the symptoms of urologic chronic pelvic pain syndrome (UCPPS) in mice. This work also aimed to test the feasibility of reversing peripheral sensitization in vivo in alleviating UCPPS symptoms. Intravesical instillation of vascular endothelial growth factor A (VEGFA) was used to induce UCPPS-like symptoms in mice. Spontaneous voiding spot assays and manual Von Frey tests were used to evaluate the severity of lower urinary tract symptoms (LUTS) and visceral hypersensitivity in VEGFA-instilled mice. Bladder smooth muscle strip contractility recordings (BSMSC) were used to identify the potential changes in myogenic and neurogenic detrusor muscle contractility at the tissue-level. Quantitative real-time PCR (qPCR) and fluorescent immunohistochemistry were performed to compare the expression levels of VEGF receptors and nociceptors in lumbosacral dorsal root ganglia (DRG) between VEGFA-instilled mice and saline-instilled controls. To manipulate primary afferent activity, Gi-coupled Designer Receptors Exclusively Activated by Designer Drugs (Gi-DREADD) were expressed in lumbosacral DRG neurons of TRPV1-Cre-ZGreen mice via targeted adeno-associated viral vector (AAVs) injections. A small molecule agonist of Gi-DREADD, clozapine-N-oxide (CNO), was injected into the peritoneum (i. p.) in awake animals to silence TRPV1 expressing sensory neurons in vivo during physiological and behavioral recordings of bladder function. Intravesical instillation of VEGFA in the urinary bladders increased visceral mechanical sensitivity and enhanced RTX-sensitive detrusor contractility. Sex differences were identified in the baseline detrusor contractility responses and VEGF-induced visceral hypersensitivity. VEGFA instillations in the urinary bladder led to significant increases in the mRNA and protein expression of transient receptor potential cation channel subfamily A member 1 (TRPA1) in lumbosacral DRG, whereas the expression levels of transient receptor potential cation channel subfamily V member 1 (TRPV1) and VEGF receptors (VEGFR1 and VEGFR2) remained unchanged when compared to saline-instilled animals. Importantly, the VEGFA-induced visceral hypersensitivity was reversed by Gi-DREADD-mediated neuronal silencing in lumbosacral sensory neurons. Activation of bladder VEGF signaling causes sensory neural plasticity and visceral hypersensitivity in mice, confirming its role of an UCPPS biomarker as identified by the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) research studies. Pharmacogenetic inhibition of lumbosacral sensory neurons in vivo completely reversed VEGFA-induced pelvic hypersensitivity in mice, suggesting the strong therapeutic potential for decreasing primary afferent activity in the treatment of pain severity in UCPPS patients.